Greenwich LifeSciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Greenwich LifeSciences, Inc. (GLSI) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents4.096.9913.4727.2028.66
Cash & Short-Term Investments4.096.9913.4727.2028.66
Accounts Receivable0.000.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.000.000.000.000.00
Total Current Assets4.096.9913.4727.2028.66
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.00
Intangible Assets0.000.010.010.010.02
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets0.000.010.010.010.00
Total Assets4.096.9913.4827.2228.68
Current Liabilities
Accounts Payable0.960.260.220.220.71
Accrued Liabilities0.600.040.040.390.06
Other Current Liabilities0.380.000.000.000.00
Total Current Liabilities1.560.290.260.391.05
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.00
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.000.000.000.000.00
Total Liabilities1.560.290.260.391.05
Stockholders' Equity
Common Stock0.010.010.010.010.01
Retained Earnings-66.15-50.36-41.47-33.65-29.08
Additional Paid-in Capital68.6757.0554.6760.470.00
Shares Outstanding13.1512.8512.8513.150.00
Total Stockholders' Equity2.536.7013.2126.8327.63
Total Liabilities & Equity4.096.9913.4827.220.00